Researchers found that pembrolizumab, an immune-activating cancer drug, lowered the risk of distant metastases in patients ...

When I first realized the scale of the challenge posed by neurodegenerative diseases, such as Alzheimer's, Parkinson's ...

EMBL researchers created SDR-seq, a next-generation tool that decodes both DNA and RNA from the same cell. It finally opens ...

A new deep learning tool accurately predicts metastatic risk in cSCC, outperforming current clinicopathological and molecular ...